FDA Announces Final Guidance for Industry on Product-Specific Guidance Meetings for Generic Drug Applications

Summary

The US Food and Drug Administration (FDA) has released a final guidance document outlining procedures for product-specific guidance meetings between the agency and applicants preparing to submit generic drug applications under the Generic Drug User Fee Amendments (GDUFA).